SCHEMBL2491463

SCHEMBL2491463

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1CC

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GCGR P47871 3/20 0.44
USP7 Q93009 2/20 0.40
ESR2 Q92731 3/20 0.38
ESR1 P03372 2/20 0.38
DHFR P00374 1/20 0.38
HEXA P06865 1/20 0.38
HEXB P07686 1/20 0.38
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
TP53 P04637 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492230 0.86 GCGR (0.38) GCGRUSP7DHFRHEXAHEXB
SCHEMBL28769956 0.84 USP7 (0.47) GCGRUSP7ESR2ESR1DHFR
SCHEMBL2492131 0.83 GCGR (0.45) GCGRDHFR
SCHEMBL9579775 0.78 GCGR (0.41) GCGRUSP7ESR2ESR1DHFR
SCHEMBL7108430 0.78 GCGR (0.41) GCGRUSP7ESR2ESR1DHFR
SCHEMBL30234292 0.78 ESR2 (0.53) GCGRUSP7ESR2ESR1DHFR
SCHEMBL2201812 0.78 ESR2 (0.53) GCGRUSP7ESR2ESR1DHFR
SCHEMBL28518728 0.77 GCGR (0.38) GCGRUSP7ESR2ESR1DHFR
Formaldehyde SCHEMBL29141443 0.77 ESR2 (0.49) GCGRUSP7ESR2ESR1KDM4E
SCHEMBL4870784 0.76 LMNA (0.39) ESR2PTGS1PTGS2BRD4BRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH GCGR 885/4885USP7 2522/4885ESR2 3511/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 GCGR 808/4885USP7 2499/4885ESR2 3465/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R GCGR 839/4885USP7 2529/4885ESR2 3449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.